Literature DB >> 21939378

Interactions of the human pathogenic Brucella species with their hosts.

Vidya L Atluri1, Mariana N Xavier, Maarten F de Jong, Andreas B den Hartigh, Renée M Tsolis.   

Abstract

Brucellosis is a zoonotic infection caused primarily by the bacterial pathogens Brucella melitensis and B. abortus. It is acquired by consumption of unpasteurized dairy products or by contact with infected animals. Globally, it is one of the most widespread zoonoses, with 500,000 new cases reported each year. In endemic areas, Brucella infections represent a serious public health problem that results in significant morbidity and economic losses. An important feature of the disease is persistent bacterial colonization of the reticuloendothelial system. In this review we discuss recent insights into mechanisms of intracellular survival and immune evasion that contribute to systemic persistence by the pathogenic Brucella species.

Entities:  

Mesh:

Year:  2011        PMID: 21939378     DOI: 10.1146/annurev-micro-090110-102905

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  108 in total

1.  Brucella Periplasmic Protein EipB Is a Molecular Determinant of Cell Envelope Integrity and Virulence.

Authors:  Julien Herrou; Jonathan W Willett; Aretha Fiebig; Daniel M Czyż; Jason X Cheng; Eveline Ultee; Ariane Briegel; Lance Bigelow; Gyorgy Babnigg; Youngchang Kim; Sean Crosson
Journal:  J Bacteriol       Date:  2019-05-22       Impact factor: 3.490

2.  Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.

Authors:  Xinghong Yang; Beata Clapp; Theresa Thornburg; Carol Hoffman; David W Pascual
Journal:  Vaccine       Date:  2016-09-14       Impact factor: 3.641

3.  Mechanism of Asp24 upregulation in Brucella abortus rough mutant with a disrupted O-antigen export system and effect of Asp24 in bacterial intracellular survival.

Authors:  Mingxing Tian; Jing Qu; Xiangan Han; Chan Ding; Shaohui Wang; Daxin Peng; Shengqing Yu
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

4.  That's the Way You Do It.

Authors:  R Martin Roop
Journal:  J Bacteriol       Date:  2019-05-22       Impact factor: 3.490

5.  Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation.

Authors:  Dong Yu; Yiming Hui; Xiaodong Zai; Junjie Xu; Long Liang; Bingxiang Wang; Junjie Yue; Shanhu Li
Journal:  Virulence       Date:  2015-06-03       Impact factor: 5.882

6.  Complete genome sequence of Brucella canis strain 118, a strain isolated from canine.

Authors:  Guangjun Gao; Jing Li; Tiefeng Li; Zhengfang Zhang; Liping Wang; Xitong Yuan; Yufei Wang; Jie Xu; Yuehua Ke; Liuyu Huang; Dali Wang; Zeliang Chen; Xingran Xu
Journal:  J Bacteriol       Date:  2012-12       Impact factor: 3.490

7.  Identification of a type IV secretion substrate of Brucella abortus that participates in the early stages of intracellular survival.

Authors:  Peter H Döhmer; Ezequiel Valguarnera; Cecilia Czibener; Juan E Ugalde
Journal:  Cell Microbiol       Date:  2013-11-03       Impact factor: 3.715

Review 8.  The changing nature of the Brucella-containing vacuole.

Authors:  Jean Celli
Journal:  Cell Microbiol       Date:  2015-05-15       Impact factor: 3.715

9.  Innate immune recognition of flagellin limits systemic persistence of Brucella.

Authors:  Jean-Jacques Letesson; Renée M Tsolis; Matthieu Terwagne; Jonathan Ferooz; Hortensia G Rolán; Yao-Hui Sun; Vidya Atluri; Mariana N Xavier; Luigi Franchi; Gabriel Núñez; Thomas Legrand; Richard A Flavell; Xavier De Bolle
Journal:  Cell Microbiol       Date:  2013-01-07       Impact factor: 3.715

10.  Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.

Authors:  Fatma I Abo El-Ela; Khaled H Hussein; Hossny A El-Banna; Amr Gamal; Sherin Rouby; Ahmed M S Menshawy; El-Shimaa El-Nahass; Shehata Anwar; Mohamed M A Zeinhom; Heba F Salem; Marawa Ahmed Yahia Al-Sayed; Hala A El-Newery; Khaled A M Shokier; Khalid A El-Nesr; H I Hosein
Journal:  AAPS PharmSciTech       Date:  2020-11-18       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.